Yes, maybe she needs to remind f herself if the core principle. “First do no harm”.
If your trial anticipates sterilisation, bone density losses, cognitive impairment etc then it should have been a non starter.
Why on earth they would allow children to stay in the program for up to 12 months if they start seeing bone density or cognitive impairment I can’t fathom.
Surely, the minute ANY of those issues start that child should be out of the program - once those drugs start affecting bone density, it’s not going to get any better unless they stop taking the drugs. As this is a known and worryingly common side effect (see the Lupron class action in America) it should be a major red flag.
But then the whole ‘study’ is a giant red flag so I guess that level of medical sanity is too much to ask for.
Lupron puberty blockers have harmed vast numbers of people in America. Surely the study designers should have looked at these first?